BioStem Technologies – Innovating in Tissue Regeneration
Jason Matuszewski, CEO, and Andrew Van Vurst, COO of BioStem Technologies discuss the development, manufacturing, and commercialization of structural ti...
3311 articles
Jason Matuszewski, CEO, and Andrew Van Vurst, COO of BioStem Technologies discuss the development, manufacturing, and commercialization of structural ti...
Nagesh Mahanthappa, Ph.D., MBA, Founder and Interim CEO of Scholar Rock, a clinical-stage biopharmaceutical company discusses spinal muscula...
Isaac Turner, Ph.D., Co-Founder and Chief Technology Officer at Curative, a next-generation healthcare company that pivoted to COVID testing in March 20...
Jorge DiMartino, MD, PhD, Chief Medical Officer and Executive VP of Clinical Development at Kronos Bio, discusses the company’s three investigational ...
Harmony Garges, Chief Medical Officer at ViiV Healthcare, a company dedicated to HIV medicines, research, and the people affected by HIV and AIDS discus...
Andrew Salzman, MD, Chief Science Officer at Innovation1 Biotech, a company that is modifying Schedule 1 molecules and creating drug innovation in the f...
Stan Abel, CEO of ProJenX, the company leading the way in the development of targeted therapies to address significant unmet medical needs in degenera...
Larry Edwards, Professor of Medicine, Division of Rheumatology and Clinical Immunology, Program Director and Vice Chairman of the Department of Medicine...
Jamie Weiner, a psychologist and co-founder of Inheriting Wisdom, a consultancy for high-net-worth families discusses his book "The Quest for Legitimacy...
Jan Wehkamp, MD, PhD, Vice President, Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC di...